Immunophenotyping of chronic lymphoid leukemias

Journal of Clinical Oncology

Volumn 26, Issue 8, 2008, Pages 1193-1194

  Dillman, Robert O ^a  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD19 ANTIBODY; CD19 ANTIGEN; CD20 ANTIBODY; CD22 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; CELL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLYCOPROTEIN P 15095; LEUKOSIALIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; LYMPHOCYTE SURFACE MARKER; MONOCLONAL ANTIBODY; LEUKOCYTE ANTIGEN;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; LYMPHOCYTE PROLIFERATION; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ARTICLE; B CELL LEUKEMIA; IMMUNOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 41649112958     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.1424     Document Type: Note

References (15)

1. Dillman RO, Beauregard JC, Lea JW, et al: Chronic lymphocytic leukemia and other chronic lymphoid proliferations: Surface marker phenotypes and clinical correlations. J Clin Oncol 1:190-197, 1983
2. Chiorazzi N, Rai KR, Ferrarini M: Chronic lymphocytic leukemia. N Engl J Med 352:804-815, 2005
3. Zola H, Swart B, Banham A, et al: CD molecules 2006: Human cell differentiation molecules. J Immunol Methods 319:1-5, 2007
4. Bernard A, Boumsell L: The clusters of differentiation (CD) defined by the First International Workshop on Human Leucocyte Differentiation Antigens. Hum Immunol 11:1-10, 1984
5. Schroff RW, Foon KA, Billing RJ, et al: Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens. Blood 59:207-215, 1982
6. Koziner B, Gebhard D, Denny T, et al: Characterization of B-cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibody. Am J Med 73:802-807, 1982
7. Aisenberg AC, Wilkes BM: Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders. Hematol Oncol 1:13-19, 1983
8. Matutes E, Polliack A: Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Hematol 4:22-47, 2000
9. Rawstron AC, Villamor N, Ritgen M, et al: International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia 21:956-964, 2007
10. Banks PM, Chan J, Cleary ML, et al: Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637-640, 1992
11. Weisenburger DD, Armitage JO: Mantle cell lymphoma: An entity comes of age. Blood 87:4483-4494, 1996
12. Sanchez ML, Almeida J, Vidriales B, et al: Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: Basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 16:1460-1469, 2002
13. Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, et al: B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinemia: A clinical, morphologic, and biologic spectrum of similar disorders. Semin Hematol 36:104-114, 1999
14. Tefferi A, Li CY, Phyliky RL: Role of immunotyping in chronic lymphocytosis: Review of the natural history of the condition in 145 adult patients. Mayo Clin Proc 63:801-806, 1988
15. Hoyer JD, Ross CW, Li CY, et al: True T-cell chronic lymphocytic leukemia: A morphologic and immunophenotypic study of 25 cases. Blood 86:1163-1169, 1995